Patent Expiry
TXMD: BIJUVA: recorded patent 10206932 expiry
November 21, 2032 · ESTRADIOL; PROGESTERONE. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- November 21, 2032
- Company
- TherapeuticsMD, Inc. (TXMD)
- Drug
- ESTRADIOL; PROGESTERONE
BioSniper AIPage context preserved
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Patent Expiry
BIJUVA: recorded patent 10206932 expiry
Orange Book application NDA210132, product 002, listed patent 10206932 expiry. Overall loss of exclusivity and current company rights: unknown.FDA source
- Company
- TherapeuticsMD, Inc. (TXMD)
- Drug
- ESTRADIOL; PROGESTERONE